Mainz Biomed B.V.
MYNZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $4 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $4 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.2% | 69% | -8.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 64.3% | 56.9% | 34.4% | 30.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,187.8% | -2,793.1% | -4,853.6% | -1,953.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,421.8% | -2,936.5% | -4,992.2% | -2,024.8% |
| EPS Diluted | -22.36 | -1.62 | -1.87 | -1.67 |
| % Growth | -1,280.2% | 13.4% | -12% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |